Mirae Asset Global Investments Co., Ltd. Neurocrine Biosciences Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 13,433 shares of NBIX stock, worth $1.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,433
Previous 3,832 250.55%
Holding current value
$1.67 Million
Previous $527,000 193.36%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$114.58 - $153.15 $1.1 Million - $1.47 Million
9,601 Added 250.55%
13,433 $1.55 Million
Q2 2024

Jul 30, 2024
SELL
$130.86 - $143.19 $1.24 Million - $1.36 Million
-9,468 Reduced 71.19%
3,832 $527,000
Q1 2024

May 01, 2024
SELL
$130.4 - $143.74 $1.78 Million - $1.97 Million
-13,688 Reduced 50.72%
13,300 $1.83 Million
Q4 2023

Jan 24, 2024
SELL
$106.07 - $132.76 $219,989 - $275,344
-2,074 Reduced 7.14%
26,988 $3.56 Million
Q3 2023

Oct 26, 2023
SELL
$94.02 - $117.1 $611,318 - $761,384
-6,502 Reduced 18.28%
29,062 $3.27 Million
Q2 2023

Aug 10, 2023
SELL
$89.53 - $104.87 $333,857 - $391,060
-3,729 Reduced 9.49%
35,564 $3.35 Million
Q1 2023

May 04, 2023
BUY
$94.11 - $123.02 $1.19 Million - $1.56 Million
12,663 Added 47.55%
39,293 $3.98 Million
Q4 2022

Feb 09, 2023
SELL
$106.72 - $127.06 $628,474 - $748,256
-5,889 Reduced 18.11%
26,630 $3.18 Million
Q3 2022

Nov 10, 2022
SELL
$92.03 - $107.81 $424,534 - $497,327
-4,613 Reduced 12.42%
32,519 $3.39 Million
Q2 2022

Jul 26, 2022
SELL
$75.79 - $100.07 $99,284 - $131,091
-1,310 Reduced 3.41%
37,132 $3.62 Million
Q1 2022

May 10, 2022
SELL
$72.45 - $94.81 $366,886 - $480,117
-5,064 Reduced 11.64%
38,442 $3.61 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $213,541 - $284,775
-2,681 Reduced 5.8%
43,506 $3.69 Million
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $486,227 - $558,727
5,642 Added 13.92%
46,187 $4.43 Million
Q2 2021

Aug 11, 2021
SELL
$89.43 - $102.27 $98,820 - $113,008
-1,105 Reduced 2.65%
40,545 $3.95 Million
Q1 2021

May 13, 2021
SELL
$87.57 - $119.4 $849,866 - $1.16 Million
-9,705 Reduced 18.9%
41,650 $4.05 Million
Q4 2020

Feb 10, 2021
BUY
$86.91 - $108.33 $1.02 Million - $1.27 Million
11,726 Added 29.59%
51,355 $4.92 Million
Q3 2020

Nov 12, 2020
BUY
$96.16 - $135.15 $114,045 - $160,287
1,186 Added 3.09%
39,629 $3.83 Million
Q2 2020

Aug 11, 2020
SELL
$85.09 - $130.36 $664,212 - $1.02 Million
-7,806 Reduced 16.88%
38,443 $4.69 Million
Q1 2020

May 12, 2020
SELL
$75.11 - $113.76 $14.5 Million - $22 Million
-193,081 Reduced 80.68%
46,249 $4 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $568,887 - $777,107
-6,554 Reduced 2.67%
239,330 $25.7 Million
Q3 2019

Nov 12, 2019
SELL
$83.82 - $101.5 $4.75 Million - $5.75 Million
-56,650 Reduced 18.73%
245,884 $22.2 Million
Q2 2019

Aug 13, 2019
SELL
$72.24 - $91.27 $274,439 - $346,734
-3,799 Reduced 1.24%
302,534 $25.5 Million
Q1 2019

May 13, 2019
BUY
$69.31 - $91.53 $2.81 Million - $3.71 Million
40,572 Added 15.27%
306,333 $27 Million
Q4 2018

Feb 11, 2019
BUY
$68.32 - $124.36 $1.08 Million - $1.97 Million
15,861 Added 6.35%
265,761 $19 Million
Q3 2018

Nov 13, 2018
BUY
$98.88 - $125.85 $16.2 Million - $20.7 Million
164,306 Added 191.96%
249,900 $30.7 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $399,240 - $561,958
5,302 Added 6.6%
85,594 $8.41 Million
Q1 2018

May 10, 2018
BUY
$75.88 - $92.43 $2.04 Million - $2.49 Million
26,930 Added 50.47%
80,292 $6.66 Million
Q4 2017

Feb 12, 2018
BUY
$58.53 - $77.59 $2.21 Million - $2.92 Million
37,690 Added 240.49%
53,362 $4.14 Million
Q3 2017

Nov 08, 2017
BUY
$47.97 - $61.28 $751,785 - $960,380
15,672
15,672 $961,000

Others Institutions Holding NBIX

# of Institutions
621
Shares Held
95.7M
Call Options Held
583K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email